All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study

Previous studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from hea...

Full description

Saved in:
Bibliographic Details
Main Authors: Deng Li, Peng Wang, Yuxi Li, Zhongyu Xie, Le Wang, Hongjun Su, Wen Deng, Yanfeng Wu, Huiyong Shen
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2015/484528
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560518129254400
author Deng Li
Peng Wang
Yuxi Li
Zhongyu Xie
Le Wang
Hongjun Su
Wen Deng
Yanfeng Wu
Huiyong Shen
author_facet Deng Li
Peng Wang
Yuxi Li
Zhongyu Xie
Le Wang
Hongjun Su
Wen Deng
Yanfeng Wu
Huiyong Shen
author_sort Deng Li
collection DOAJ
description Previous studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from healthy donors were pretreated with ATRA and cocultured with CD3/28-activated peripheral blood mononuclear cells (PBMCs) derived from AS patients. Frequencies of Th17 and regulatory T (Treg) cells were analyzed using flow cytometry. The secretion and the mRNA level of key cytokines were measured with cytometric bead array and quantitative real-time PCR, respectively. ATRA pretreatment increased interleukin-6 (IL-6) secretion of MSCs. Th17 and Treg subset populations were increased and reduced by ATRA-pretreated MSCs, respectively. ATRA-pretreated MSCs significantly decreased not only the vital pathogenic cytokine in AS, tumor necrosis factor-α (TNF-α), but also AS-boosting factors interleukin-17 (IL-17A) and interferon-γ (IFN-γ). These results indicated that IL-6 may be a potential protective factor in AS and highlighted the promising role of ATRA in improving the efficacy of MSC-based treatment of AS.
format Article
id doaj-art-51fc421ccd6a4824a4c5a2647eb082b9
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-51fc421ccd6a4824a4c5a2647eb082b92025-02-03T01:27:16ZengWileyStem Cells International1687-966X1687-96782015-01-01201510.1155/2015/484528484528All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro StudyDeng Li0Peng Wang1Yuxi Li2Zhongyu Xie3Le Wang4Hongjun Su5Wen Deng6Yanfeng Wu7Huiyong Shen8Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaCenter for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaDepartment of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, ChinaPrevious studies have demonstrated the immunosuppressive effects of both all-trans retinoic acid (ATRA) and mesenchymal stem cells (MSCs). The present study aimed to assess the immunoregulatory effects of ATRA on MSCs in the treatment of ankylosing spondylitis (AS). Bone marrow-derived MSCs from healthy donors were pretreated with ATRA and cocultured with CD3/28-activated peripheral blood mononuclear cells (PBMCs) derived from AS patients. Frequencies of Th17 and regulatory T (Treg) cells were analyzed using flow cytometry. The secretion and the mRNA level of key cytokines were measured with cytometric bead array and quantitative real-time PCR, respectively. ATRA pretreatment increased interleukin-6 (IL-6) secretion of MSCs. Th17 and Treg subset populations were increased and reduced by ATRA-pretreated MSCs, respectively. ATRA-pretreated MSCs significantly decreased not only the vital pathogenic cytokine in AS, tumor necrosis factor-α (TNF-α), but also AS-boosting factors interleukin-17 (IL-17A) and interferon-γ (IFN-γ). These results indicated that IL-6 may be a potential protective factor in AS and highlighted the promising role of ATRA in improving the efficacy of MSC-based treatment of AS.http://dx.doi.org/10.1155/2015/484528
spellingShingle Deng Li
Peng Wang
Yuxi Li
Zhongyu Xie
Le Wang
Hongjun Su
Wen Deng
Yanfeng Wu
Huiyong Shen
All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
Stem Cells International
title All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
title_full All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
title_fullStr All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
title_full_unstemmed All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
title_short All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study
title_sort all trans retinoic acid improves the effects of bone marrow derived mesenchymal stem cells on the treatment of ankylosing spondylitis an in vitro study
url http://dx.doi.org/10.1155/2015/484528
work_keys_str_mv AT dengli alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT pengwang alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT yuxili alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT zhongyuxie alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT lewang alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT hongjunsu alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT wendeng alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT yanfengwu alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy
AT huiyongshen alltransretinoicacidimprovestheeffectsofbonemarrowderivedmesenchymalstemcellsonthetreatmentofankylosingspondylitisaninvitrostudy